United States

Back to map

Showing 71-80 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
Genome-scale CRISPR screens identify ER export cargo proteins as mediators for β-cell stress response and antigen presentation Indiana Biosciences Research Institute Isabela Lovizutto Iessi Longo Cures 01-March-2023 to 28-February-2026 $135,307.11
Exploiting SDF2L1 to protect against beta cell death and dysfunction in T1D Indiana Biosciences Research Institute Michael Kalwat Cures 01-December-2024 to 30-November-2027 $748,169.00
A smart Semiconductor based Continuous Diabetes Monitoring Platform Integrated Medical Sensors Inc Muhammad Mujeeb-U-Rahman Improving Lives 01-June-2022 to 31-May-2025 $500,000.00
Adult T1D Detection at Geisinger IQVIA, Inc. Nadejda Leavitt Cures 01-July-2023 to 31-December-2025 $890,727.00
Advancing T1D Detection and Care Through AI IQVIA, Inc. Nadejda Leavitt Cures 01-February-2025 to 31-January-2026 $345,083.00
JDRF-IQVIA Adult T1D Detection IQVIA, Inc. Nadejda Leavitt Cures 01-October-2022 to 31-August-2025 $953,780.00
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes iTolerance, Inc. Camillo Ricordi Cures 01-June-2022 to 31-August-2025 $850,000.00
A Phase 2 Study Evaluating Short-Term Efficacy of Tonabersat (Xiflam) for Diabetic Macular Edema Jaeb Center for Health Research Adam Glassman Improving Lives 01-September-2022 to 01-January-2026 $273,424.00
Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening Jaeb Center for Health Research Adam Glassman Improving Lives 01-February-2021 to 31-January-2026 $750,000.00
JDRF T1D Coordinating Center Jaeb Center for Health Research Judy Sibayan Transportfolio 01-August-2019 to 31-August-2027 $2,914,531.01